Multi-operating system

Apply for Patent – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Z124 patent solves the following problem:

This relates generally to the field of mobile environments Computing, and especially to support many user environment through the use of multiple operating systems on a single mobile computing device.

Our analysis of this patent is as follows:

Z124’s patent US 8898443 B2 deals with Multi-operating system.
A mobile computing devices with a mobile operating systems and desktop operating systems running simultaneously and independently on a shared grain without virtualization. The mobile operating system provides a user experience for mobile computing devices that case the mobile environment. The desktop operating system provides a complete desktop user experience when the mobile computing device is docked to a secondary terminal around. The mobile computing device may be a smartphone running the Android mobile OS and a complete desktop Linux distribution on a modified Android kernel.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Antibody to secreted polypeptide

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Incyte Corporation patent solves the following problem:

Protein transport and secretion is necessary for cellular function. Transport protein mediated a signal peptide located at amino terminal protein dad or hidden. The signal peptide consists of ten to twenty hydrophobic amino acids that target the nascent protein from ribosome to a particular membrane bound compartment such as the endoplasmic reticulum (ER). Protein target the ER to continue by way secretory or stay in any of the secretory organelles such as the ER, Golgi apparatus, or lysosomes. Proteins that transit through the secretory way be secreted into the extracellular space or left in the plasma membrane. Protein retained in the plasma membrane includes one or more transmembrane domains, each consisting of 20 hydrophobic amino acid residues. Secreted protein normally synthesized as inactive precursors because of the post-translation processing events during transit through the secretory way. Such events include glycosylation, proteolysis, and removal of the signal peptide with a signal peptidase. The other events that occur during the transport proteins include chaperone-dependent expression and folding of nascent proteins and protein interaction with a receptor or pore complex. Examples of secreted proteins with amino terminal signal peptide described below and include protein with an important role in cell-to-cell signaling. Such proteins include transmembrane receptor and cell surface markers, extracellular matrix molecules, cytokines, hormones, growth and diversity factor, enzyme, neuropeptides, vasomediators, cell surface markers, and antigen recognition molecules. (Reviewed in Alberts, B. et al. (1994) Molecular Biology of the Cell, garland Publishing, New York, NY, pp. 557-560, 582-592.)

Our analysis of this patent is as follows:

Incyte Corporation’s patent US 8889833 B2 deals with Antibody to secreted polypeptide.
human invention provides secreted protein (SECP) and polynucleotides which identify and encode SECP. invention also provides expression vector, host cells, antibodies, agonists and antagonists. invention also provides methods for diagnosing, treating, or preventing diseases associated with aberrant expression of SECP.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Flame-retarded thermoplastic compositions of high thermomechanical strength, in particular for electric cables

Apply for Patent – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Arkema France patent solves the following problem:

Our analysis of this patent is as follows:

Arkema France’s patent US 8883899 B2 deals with Flame-retarded thermoplastic compositions of high thermomechanical strength, in particular for electric cables.
A flame-retarded thermoplastic composition including a graft copolymer containing polyamide blocks and composed of a polyolefin backbone and on average at least one polyamide graft, in which the grafts attached to the backbone by residues of an unsaturated monomer (X) with a function can react a polyamide, the residues of the unsaturated monomer (X) is attached to the backbone by grafting or copolymerization from its double bond, wherein the composition includes: between 60% and 70% of the weight of graft copolymer containing polyamide blocks, between 22% and 28% of the weight of poly (pentabromobenzyl acrylate), between 4% and 8% of the weight of a synergistic flame retardant selected from antimony trioxide, tin derivatives, molybdenum and / or bismuth and boron and zinc oxide, calcium borates, calcium sulphate and / or zinc stannate, between 0.5% and 5% in weight of organophilic treated clay.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Nutritional compositions with coated lipid globules

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The N. V. Nutricia patent solves the following problem:

Breast-feeding is the preferred method of infant feeding. However, there are circumstances that make breast-feeding impossible or less attractive. In the case of children's formula is a good alternative. The composition of modern infant formulas is adapted in such a way that will meet many of the special nutritional needs of the fast growing and developing infant.

Our analysis of this patent is as follows:

N. V. Nutricia’s patent US 8883219 B2 deals with Nutritional compositions with coated lipid globules.
The present invention relates to a nutritional composition for children and / or children consisting of a lipid component has a lipid globules coated with phospholipids. composition used for increasing bone mineral content, bone mineral density, prevent osteoporosis, and / or control ostopenia.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Nasal administration

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Optinose As patent solves the following problem:

Our analysis of this patent is as follows:

Optinose As’s patent US 8875704 B2 deals with Nasal administration.
A delivery device and method to deliver a powdered substance, in particular a triptan, such as sumatriptan, the anal region of a nasal cavity of a subject, in particular for the treatment of headache head, for example, cluster headaches and migraine, and neuropathic pain, the delivery device comprising: a nosepiece for insertion into a nasal cavity of a subject with which the powdered substance delivered to the posterior region of the nasal cavity of the subject, in particular on the bottom two thirds of the nasal cavity; and a substance supply unit that is operable to deliver the powdered substance through the nosepiece.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.